| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 01/03/2008 | CA2655913A1 Novel 6-5 system bicyclic heterocyclic derivative and its pharmaceutical utility |
| 01/02/2008 | EP1873147A1 Phthalazinone derivative and pharmaceutical comprising the same |
| 01/02/2008 | EP1872786A1 Use of immunostimulatory oligonucleotides for preventing or reducing antigen-stimulated, granulocyte-mediated inflammation |
| 01/02/2008 | EP1872783A1 Therapeutic agent for corneal/conjunctival disorder |
| 01/02/2008 | EP1871381A2 Therapeutic substituted cyclopentanones |
| 01/02/2008 | EP1871366A2 Drug delivery systems for treatment of diseases or conditions |
| 01/02/2008 | EP1537069B1 ANALOGUES OF LIPID MEDIATORS DERIVED FROM OMEGA-3 PUFAs AND METHODS OF USE |
| 01/02/2008 | EP1471898B1 Lutein/zeaxanthin for glare protection |
| 01/02/2008 | EP1406859B1 Substituted 4-aminocyclohexanol derivatives |
| 01/02/2008 | EP1268404B1 Malonamic acids and derivatives thereof as thyroid receptor ligands |
| 01/02/2008 | CN101096684A Zinc finger protein DPZF gene knock-out mice model and its usage |
| 01/02/2008 | CN101096337A Aralkyl-tetrahydro-pyridines, their preparation and pharmaceutical compositions containing same |
| 01/02/2008 | CN101095945A Fibre connexin active tears and production method thereof |
| 01/02/2008 | CN101095939A Eyedrops and method for preparing the same |
| 01/02/2008 | CN101095847A Chinese traditional medicine composition for treating diabetes deafness |
| 01/02/2008 | CN101095776A Chinese patent drug for treating diabetes deafness |
| 01/02/2008 | CN101095775A Chinese traditional medicine for treating diabetes deafness |
| 01/02/2008 | CN101095774A Chinese traditional medicine preparations for treating diabetes deafness |
| 01/02/2008 | CN101095763A Decoction medicine for treating acute catarrhal conjunctivitis and method for preparing the same |
| 01/02/2008 | CN101095722A Eye drops and preparation method thereof |
| 01/02/2008 | CN101095711A The extracting of chrysanthemum rice extracts and the method for making the preparations thereof |
| 01/02/2008 | CN101095695A Liposome artificial tear eye drops |
| 01/02/2008 | CN101095514A Health care food having a function of relieving vision fatigue |
| 01/02/2008 | CN100358892C 7-oxo pyridopyrimidines |
| 01/02/2008 | CN100358595C Safety shield system for prefilled syringe |
| 01/02/2008 | CN100358528C Use of mometasone furoate for treating airway passage and lung diseases |
| 01/02/2008 | CN100358514C Remedies for allergic eye diseases |
| 01/01/2008 | US7314934 Substituted 2,4,8-trisubstituted-8H-pyrido[2,3-d]pyrimidin-7-one compounds, e.g., 8-(2,6-Difluoro-phenyl)-4-(4-fluoro-2-methyl-phenyl)-2-(2-hydroxy-1-hydroxymethyl-ethylamino)-8H-pyrido[2,3-d]pyrimidin-7-one; CSBP/p38 kinase inhibitors |
| 01/01/2008 | US7314889 Compounds and their use in medicine, process for their preparation and pharmaceutical compositions containing them |
| 01/01/2008 | US7314881 2,4,8-trisubstituted-8H-pyrido[2,3-d]pyrimidin-7-one compounds |
| 01/01/2008 | US7314873 (Halo-benzo carbonyl)heterobi cyclic p38 linase inhibiting agents |
| 01/01/2008 | US7314625 Generating polyclonal antisera that reduce adherence of the microorganism expressing the Type IV pilin loop sequence to the epithelial cells |
| 12/27/2007 | WO2007149451A2 Cycloalkanopyrrolocarbazole derivatives and the use thereof as parp, vegfr2 and mlk3 inhibitors |
| 12/27/2007 | WO2007148837A1 Composition capable of promoting the production of collagen |
| 12/27/2007 | WO2007148744A1 Prophylactic or therapeutic agent for corneal/conjunctival disorder comprising fumaric acid derivative as active ingredient |
| 12/27/2007 | WO2007148697A1 Inhibitor of expression of nuclear transcription factor ap-1, and pharmaceutical product and product using the inhibitor |
| 12/27/2007 | WO2007127844A3 Formulations containing amide derivatives of carboxylic acid nsaids for topical administration to the eye |
| 12/27/2007 | WO2007117971A3 Ocular allergy treatments |
| 12/27/2007 | WO2007106708A3 Combinations of the angiotensin ii antagonist valsartan and the nep inhibitor daglutril |
| 12/27/2007 | WO2007095250A3 Compositions and methods for inhibiting optic nerve damage |
| 12/27/2007 | WO2007020671A3 Ophthalmic compositions containing mucoadhesive polysaccharides able to promote corneal re-epithelization |
| 12/27/2007 | WO2003066824A3 Albumin-fused kunitz domain peptides |
| 12/27/2007 | US20070299124 Formulations and methods for treating dry eye |
| 12/27/2007 | US20070299092 Quinone Substituted Quinazoline and Quinoline Kinase Inhibitors |
| 12/27/2007 | US20070299075 e.g. 1-[4-(4-Fluoro-2-methyl-1H-indol-5-yloxy)-5-methyl-pyrrolo[2,1-f][1,2,4]triazin-6-yloxy]-4-(aminosulfonyl)aminobutan-2-ol; inhibit the tyrosine kinase activity of endothelial and fibroblast growth factors receptors; angiogenesis inhibitor; anticarcinogenic agent |
| 12/27/2007 | US20070299073 Imidazolyl derivatives |
| 12/27/2007 | US20070299070 Such as 5-(benzyloxy)-N-[4-(morpholinomethyl)phenyl]-1H-indole-2-carboxamide and 5-(benzyloxy)-N-[4-(morpholinomethyl)phenyl]-1H-benzimidazole-2-carboxamide; melanin-concentrating hormone receptor antagonist, useful for treating obesity |
| 12/27/2007 | US20070299004 Methods of providing therapeutic effects using cyclosporin compontnts |
| 12/27/2007 | US20070298997 Compounds useful in treating diabetic microvascular complications and age-related macular degeneration |
| 12/27/2007 | US20070298127 Diazene-bridged crown ether lithium compounds and methods for their use |
| 12/27/2007 | US20070298124 ammonium trichloro(dioxyethylene-O,O')tellurate; epilepsy, inflammatory bowel disease, Crohn's disease and ulcerative colits |
| 12/27/2007 | US20070298123 Anti-angiogenic compositions and methods of use |
| 12/27/2007 | US20070298076 Method for reducing or preventing transplant rejection in the eye and intraocular implants for use therefor |
| 12/27/2007 | US20070297989 Novel anti-inflammatory androstane derivatives |
| 12/27/2007 | US20070297981 Formulations and methods for treating dry eye |
| 12/27/2007 | CA2657967A1 Cyclopentane derivatives as antiglaucoma agents |
| 12/27/2007 | CA2655014A1 Cycloalkanopyrrolocarbazole derivatives and the use thereof as parp, vegfr2 and mlk3 inhibitors |
| 12/26/2007 | EP1870410A1 Substituted arylpyrazolopyridines and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of same |
| 12/26/2007 | EP1870409A1 Benzimidazole compound |
| 12/26/2007 | EP1870402A1 2,6-quinolinyl and 2,6-naphthyl derivatives, processes for preparing them and their uses as VLA-4 inhibitors |
| 12/26/2007 | EP1870099A1 Protective agent for retinal neuronal cell comprising indazole derivative as active ingredient |
| 12/26/2007 | EP1870098A2 Combined use of valsartan and calcium channel blockers for therapeutic purposes |
| 12/26/2007 | EP1870092A2 Ocular implant made by a double extrusion process |
| 12/26/2007 | EP1868685A2 11ß-HYDROXYSTEROID DEHYDROGENASES |
| 12/26/2007 | EP1868620A1 Stable ophthalmic oil-in-water emulsions with sodium hyaluronate for alleviating dry eye |
| 12/26/2007 | EP1491531B1 (1-indanone)-(1,2,3,6-tetrahydropyridine) derivative |
| 12/26/2007 | EP1233769B1 Imidazole derivatives |
| 12/26/2007 | EP0778848B1 Agents for inducing apoptosis and applications of said agents in therapy |
| 12/26/2007 | CN101094674A Use of n-desmethylclozapine to treat human neuropsychiatric disease |
| 12/26/2007 | CN101094666A Improvement of image quality in the eye |
| 12/26/2007 | CN101092432A Superoxide dismutase mimics for the treatment of ocular disorders and diseases |
| 12/26/2007 | CN101092409A C-aryl glucoside sglt2 inhibitors and method |
| 12/26/2007 | CN101092388A Fluoro substituted cycloalkanoindoles, compositions containing such compounds and methods of treatment |
| 12/26/2007 | CN101091723A External remedy for curing purulent otitis media and preparation method |
| 12/26/2007 | CN101091703A Renin inhibitor-containing synergetic compositions designated for treatment of cardiovascular disease |
| 12/26/2007 | CN100357244C Aspirin-triggered lipid mediators |
| 12/25/2007 | US7312358 Dysmenorrhea; congestive heart failure; liver disorders; vision defects |
| 12/25/2007 | US7312344 Dimeric isoflavones |
| 12/25/2007 | US7312342 Process for the preparation of (3-cyano-1h-indol-7-yl) (4-(4-fluorophenethyl) piperazin-1-yl)-methanone and salts thereof |
| 12/25/2007 | US7312230 Carboxylic acid derivatives as IP antagonists |
| 12/25/2007 | US7312224 Pyrimidine derivatives |
| 12/25/2007 | US7312203 1H-8-oxa-1-aza-dibenzo[e,h]azulene; dual inhibitors of tumour necrosis factor(alpha) and interleukin 1; antiinflammatory, analgesics |
| 12/25/2007 | US7311917 Membrane proteins; fusion proteins; vaccines; kits |
| 12/21/2007 | WO2007146684A1 Ophthalmic compositions comprising a branched, glycerol compound and a cationic antimicrobial |
| 12/21/2007 | WO2007145306A1 Element having long blood-circulating time which is degradable selectively in tumor tissue |
| 12/21/2007 | WO2007144621A2 Protection against and treatment of age related macular degeneration |
| 12/21/2007 | WO2007144334A1 Prevention and treatment of otitis media with non-pathogenic bacterial strains |
| 12/21/2007 | WO2007144203A1 Substituted arylpyrazolopyridines and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of same |
| 12/21/2007 | CA2655106A1 Substituted gamma lactams as therapeutic agents |
| 12/21/2007 | CA2655088A1 Protection against and treatment of age related macular degeneration |
| 12/21/2007 | CA2654105A1 Substituted arylpyrazolopyridines and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of same |
| 12/21/2007 | CA2652517A1 Prevention and treatment of otitis media with non-pathogenic bacterial strains |
| 12/20/2007 | US20070293560 Compounds and compositions |
| 12/20/2007 | US20070293558 Ophthalmic Compositions for Treating Ocular Hypertension |
| 12/20/2007 | US20070293556 Prophylactic or Therapeutic Agent for Diabetic Maculopathy |
| 12/20/2007 | US20070293555 4-methoxy-benzoic acid 1-imidazol-1-yl methyl-2-(4-fluorophenoxy)-ethyl ester; N-[(1-imidazol-1-yl methyl)-2-phenoxy-ethyl]-4-iodo-benzamide; cancer, inflammation, septic shock, infertility, preterm labor, pain, or an ischemia |
| 12/20/2007 | US20070293524 Salts, hydrates, solvatesand/or N-oxides; inhibit the IgE and/or IgG receptor signaling cascades that lead to the release of chemical mediators; Syk kinase inhibitors; inhibiting an Fc receptor signal transduction cascade |
| 12/20/2007 | US20070293523 inhibitors of immunoglobulin E or G receptor signaling cascades; Syk kinase inhibitors; use as antiallergic, antiinflammatory agents |
| 12/20/2007 | US20070293522 2,4-pyrimidinediamine compounds and their uses |
| 12/20/2007 | US20070293521 inhibitors of immunoglobulin E or G receptor signaling cascades; Syk kinase inhibitors; use as antiallergic, antiinflammatory agents |